Company intelligence / Profile preview
Altova Healthcare
- Ownership
- Private
- Employees
- ~71
- Development stage
- Other
Overview
Altova Healthcare's products are commercialized globally; the company holds multiple international regulatory approvals (US-FDA OTC, Australia-TGA OTC, WHO-GMP) and supplies to regulated markets. Clinical results for individual formulations are not publicly reported but many are generic formulations with established efficacy and safety profiles.
- Therapeutic areas
- Infectious DiseasesDermatologyOtherGastroenterology
- Modalities
- Small moleculeCreamsOintmentsGelsLotionsBiologic
- Industry
- Biotech
Drug pipeline
3 assets2 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Altova Healthcare.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Altova Healthcare.